Clopidogrel vs Nivolumab

Clopidogrel vs Nivolumab: Overview

This comparison examines the pharmacological differences between Clopidogrel and Nivolumab.

Mechanism of Action

Clopidogrel: Irreversibly blocks P2Y12 ADP receptor on platelets.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Clopidogrel — 6 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Clopidogrel — C16H16ClNO2S.

Molecular Weight: Clopidogrel — 321.8220 g/mol.

Type: Clopidogrel — Small molecule; Nivolumab — Antibody.